Our recent studies have shown that global deletion of CD11b (CD11b−/−) results in significantly larger tumors in mice, partly due to increase in immunosuppressive TAMs in the TME (34), suggesting that active CD11b may have an important role in controlling tumor growth. This evidence concerns the gene ITGAM and neoplasm.